These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23935204)

  • 41. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort.
    Kaleebu P; Ross A; Morgan D; Yirrell D; Oram J; Rutebemberwa A; Lyagoba F; Hamilton L; Biryahwaho B; Whitworth J
    AIDS; 2001 Feb; 15(3):293-9. PubMed ID: 11273208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.
    Jumare J; Ndembi N; El-Kamary SS; Magder L; Hungerford L; Burdo T; Eyzaguirre LM; Dakum P; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
    Clin Infect Dis; 2018 Apr; 66(9):1448-1453. PubMed ID: 29182762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Human immunodeficiency virus type 1 subtypes in Djibouti].
    Abar AE; Jlizi A; Darar HY; Ben Nasr M; Abid S; Kacem MA; Slim A
    Arch Inst Pasteur Tunis; 2012; 89(1-4):33-7. PubMed ID: 24834659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001.
    Meloni ST; Sankalé JL; Hamel DJ; Eisen G; Guéye-Ndiaye A; Mboup S; Kanki PJ
    J Virol; 2004 Nov; 78(22):12455-61. PubMed ID: 15507632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of HIV-1 Subtypes on AIDS Progression in a Brazilian Cohort.
    Leite TC; Campos DP; Coelho AB; Teixeira SL; Veloso V; Morgado MG; Guimarães ML
    AIDS Res Hum Retroviruses; 2017 Jan; 33(1):41-48. PubMed ID: 27418261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba.
    Kouri V; Khouri R; Alemán Y; Abrahantes Y; Vercauteren J; Pineda-Peña AC; Theys K; Megens S; Moutschen M; Pfeifer N; Van Weyenbergh J; Pérez AB; Pérez J; Pérez L; Van Laethem K; Vandamme AM
    EBioMedicine; 2015 Mar; 2(3):244-54. PubMed ID: 26137563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.
    Eller MA; Opollo MS; Liu M; Redd AD; Eller LA; Kityo C; Kayiwa J; Laeyendecker O; Wawer MJ; Milazzo M; Kiwanuka N; Gray RH; Serwadda D; Sewankambo NK; Quinn TC; Michael NL; Wabwire-Mangen F; Sandberg JK; Robb ML
    J Infect Dis; 2015 May; 211(10):1574-84. PubMed ID: 25404522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan.
    Carr JK; Nadai Y; Eyzaguirre L; Saad MD; Khakimov MM; Yakubov SK; Birx DL; Graham RR; Wolfe ND; Earhart KC; Sanchez JL
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):570-5. PubMed ID: 16044009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations.
    Esbjörnsson J; Mild M; Månsson F; Norrgren H; Medstrand P
    PLoS One; 2011 Feb; 6(2):e17025. PubMed ID: 21365013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa.
    Kijak GH; Sanders-Buell E; Wolfe ND; Mpoudi-Ngole E; Kim B; Brown B; Robb ML; Birx DL; Burke DS; Carr JK; McCutchan FE
    AIDS Res Hum Retroviruses; 2004 May; 20(5):521-30. PubMed ID: 15186527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development, evaluation, and validation of an oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG.
    Njai HF; Van der Auwera G; Ngong CA; Heyndrickx L; Sawadago S; Whittle H; Nyambi P; Colebunders R; van der Groen G; Janssens W
    J Clin Microbiol; 2004 Apr; 42(4):1428-33. PubMed ID: 15070984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau.
    Xiang Z; Ariyoshi K; Wilkins A; Dias F; Whittle H; Breuer J
    AIDS Res Hum Retroviruses; 1997 Apr; 13(6):501-5. PubMed ID: 9100992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage.
    Vergne L; Bourgeois A; Mpoudi-Ngole E; Mougnutou R; Mbuagbaw J; Liegeois F; Laurent C; Butel C; Zekeng L; Delaporte E; Peeters M
    Virology; 2003 Jun; 310(2):254-66. PubMed ID: 12781713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity.
    Hamel DJ; Sankalé JL; Eisen G; Meloni ST; Mullins C; Gueye-Ndiaye A; Mboup S; Kanki PJ
    AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1189-96. PubMed ID: 17961103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low Postseroconversion CD4
    Palm AA; Lemey P; Jansson M; Månsson F; Kvist A; Szojka Z; Biague A; da Silva ZJ; Rowland-Jones SL; Norrgren H; Esbjörnsson J; Medstrand P
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Molecular Epidemiological Analysis of HIV-1 pol Gene Sequences Isolated in Istanbul, Turkey].
    Sayan M; Kumbasar Karaosmanoğlu H; Mete B; Gündüz A; Aydın O; Yemişen M; Uzun N; Tabak F
    Mikrobiyol Bul; 2013 Jan; 47(1):87-97. PubMed ID: 23390906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical progression in early and late stages of disease in a cohort of individuals infected with human immunodeficiency virus-2 in Guinea-Bissau.
    Norrgren H; da Silva Z; Biague A; Andersson S; Biberfeld G
    Scand J Infect Dis; 2003; 35(4):265-72. PubMed ID: 12839157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human immunodeficiency virus type 1 subtypes differ in disease progression.
    Kanki PJ; Hamel DJ; Sankalé JL; Hsieh Cc; Thior I; Barin F; Woodcock SA; Guèye-Ndiaye A; Zhang E; Montano M; Siby T; Marlink R; NDoye I; Essex ME; MBoup S
    J Infect Dis; 1999 Jan; 179(1):68-73. PubMed ID: 9841824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form.
    Abecasis AB; Lemey P; Vidal N; de Oliveira T; Peeters M; Camacho R; Shapiro B; Rambaut A; Vandamme AM
    J Virol; 2007 Aug; 81(16):8543-51. PubMed ID: 17553886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calculation and use of an HIV-1 disease progression score.
    Roussanov BV; Taylor JM; Giorgi JV
    AIDS; 2000 Dec; 14(17):2715-22. PubMed ID: 11125890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.